<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-125773" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Mo99 - Tc99m Generator</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Riya</given-names>
          </name>
          <aff>All India Institute of Medical Sciences, Rishikesh</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hashmi</surname>
            <given-names>Muhammad F.</given-names>
          </name>
          <aff>National Health Service</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Riya Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Hashmi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-125773.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Radionuclide production is a crucial component in nuclear imaging and therapeutic modalities. More than 90% of its production is used for diagnostic purposes. The majority of the radionuclides are produced in a nuclear reactor and a cyclotron. However, it is impractical to set up an imaging laboratory near a nuclear reactor or a cyclotron; therefore, a generator serves as a convenient system for on-site production and extraction of commonly used radionuclides such as 99m-Tc (6 hours) from its parent nuclide molybdenum 99 (66 hours). Other less widely used generator systems include 132-Te (3.2 days)/132-I (2.3 hours), 68-Ge (271 days)/ 68-Ga (68 minutes).</p>
      </sec>
      <sec id="article-125773.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>
<bold>Basic Characteristics</bold>
</p>
        <p>One of the indispensable characteristics of an ideal radiopharmaceutical is a short half-life. Larger doses could be used with minimal radiation burden to the patient for better imaging quality. Besides, the radionuclide produced should have high specific activity with minimal impurities.<xref ref-type="bibr" rid="article-125773.r1">[1]</xref>&#x000a0;The radionuclide should be easily labeled with an appropriate pharmaceutical such as a peptide, colloid, or ligand. These essential characteristics are satisfied by a generator system involved in the production of 99m-Tc with excellent radiation characteristics. Tucker and Greene developed the first technetium-99m generator in 1958. In 1960, it was used as a medical tracer for the first time by Richards.<xref ref-type="bibr" rid="article-125773.r2">[2]</xref><xref ref-type="bibr" rid="article-125773.r3">[3]</xref><xref ref-type="bibr" rid="article-125773.r4">[4]</xref></p>
        <p>The generator consists of an alumina (Al2O3) anion exchange cylindrical column with fission-produced Mo-99 adsorbed onto it, contained within a lead shield for radiation protection. Lead blocks the gamma (Tc) and beta- (Mo) radiations. Around 5-10 g of alumina is used in the column.<xref ref-type="bibr" rid="article-125773.r5">[5]</xref>&#x000a0;Technetium-99m is extracted in an evacuated vial using 0.9% normal saline without removing Mo, through column chromatography, colloquially known as moly cow (milking). This is also defined as an elution.<xref ref-type="bibr" rid="article-125773.r6">[6]</xref>&#x000a0;</p>
        <p>After every 23 hours, the maximum activity of 99m-Tc is obtained. It gradually builds up according to the radioactive decay of molybdenum. Therefore, in most laboratories, elution is usually carried out every 24 hours to increase the generator's efficiency. However, elution can be carried out more than once a day for emergency studies since 50% of the maximum activity is reached with 4-5 hours of initial elution.<xref ref-type="bibr" rid="article-125773.r7">[7]</xref>&#x000a0;The eluate, sodium pertechnetate (TcO4-) volume is about 2-3 ml and has an expiration period of 12 hours.</p>
        <p>
<bold>Types of Generator</bold>
</p>
        <p>There are two types of generators available commercially, wet and dry type systems. The wet system has a 0.9% normal saline reservoir, and the eluate is accumulated in a particular sterile evacuated vial at a collection port. In contrast, a dry system is commonly available at imaging labs and has two ports for elution and evacuated vials.<xref ref-type="bibr" rid="article-125773.r8">[8]</xref></p>
        <p>
<bold>Theoretical yield of 99m-Tc</bold>
</p>
        <p>The level of technetium-99m varies according to growth and decay effects. The radioactive decay is continuous within the generator system. A transient equilibrium is attained as the half-lives of Mo and Tc differ by a factor of 11. Approximately 87% of molybdenum decays into 99m-Tc and 13% into stable Tc-99 (2.1 x 10^5years). Also, 99m-Tc decays to Tc-99 by isomeric transition with the emission of 140-KeV gamma rays.<xref ref-type="bibr" rid="article-125773.r9">[9]</xref></p>
        <p>Although 99-Tc and 99m-Tc have similar physical and chemical properties, they differ in labeling efficiency. Nevertheless, it is not problematic from a health standpoint.<xref ref-type="bibr" rid="article-125773.r10">[10]</xref></p>
        <p>Sometimes, it becomes prudent to calculate the theoretical yield of 99m-Tc for add-on emergency studies. Equation 1 provides a theoretical yield of 99m-Tc via the Molybdenum generator at a given time.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>ATc = 0.957(AMo)i [e^-0.0105t - e^-0.1155t] + [(ATc)i (e^-0.1155t)] (Eq. 1)<xref ref-type="bibr" rid="article-125773.r11">[11]</xref></p>
          </list-item>
        </list>
        <p>Because Mo has a half-life of 66 hours (2.8 days), a generator can be used for up to two weeks.</p>
        <p>This calculation is often employed by institutional set-up to purchase an appropriately sized generator to calculate enough residual activity on the last day of the workweek.<xref ref-type="bibr" rid="article-125773.r12">[12]</xref></p>
      </sec>
      <sec id="article-125773.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Quality Control of 99m-Tc Eluate with Clinical Implications</bold>
</p>
        <p>Before administering radiopharmaceuticals to patients, it is mandatory to perform quality check steps with every elution. This additional step results in minimal radiation exposure with maximum clinical benefit. The chances of having impurities in an eluate increase when elution is not carried out daily.<xref ref-type="bibr" rid="article-125773.r13">[13]</xref>&#x000a0;Some of the most common impurities are discussed below in brief.</p>
        <p>Mo-99 Breakthrough/Radionuclide Impurity</p>
        <p>This usually happens near the generator's expiry date, when Mo-99 contamination may be eluted with 99m-Tc. However, the determination of Moly's breakthrough is inescapable with every elution. USP's standard limit is less than 0.15 microCi 99-Mo/ mCi 99m-Tc at the administration time, which can be easily calculated by placing a generator equate in the lead container designed only to detect energetic 740-KeV and 780-KeV gamma rays of 99-Mo.<xref ref-type="bibr" rid="article-125773.r14">[14]</xref>&#x000a0;The particulate emissions (beta-) by 99m-Mo can be detrimental to a patient's health in the long run due to a longer half-life.</p>
        <p>The manufacturer usually performs other radionuclides contamination tests.<xref ref-type="bibr" rid="article-125773.r15">[15]</xref></p>
        <table-wrap id="article-125773.table0" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p>Radionuclide contaminants</p>
</td>
                <td rowspan="1" colspan="1">
<p>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;Safe permissible limit (per mCi 99m-Tc)</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>I-131</p>
</td>
                <td rowspan="1" colspan="1">
<p>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;0.05</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Ru-103</p>
</td>
                <td rowspan="1" colspan="1">
<p>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;0.05</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Sr-89</p>
</td>
                <td rowspan="1" colspan="1">
<p>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;0.0006</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>Sr-90</p>
</td>
                <td rowspan="1" colspan="1">
<p>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;0.00006</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>
<italic toggle="yes">Table 1 shows some important critical contaminants with safe permissible limits.</italic>
<xref ref-type="bibr" rid="article-125773.r16">[16]</xref>
</p>
        <p>
<bold>Aluminum Breakthrough/Chemical Impurity</bold>
</p>
        <p>&#x000a0;The alumina column in the generator bed contributes to its contamination, especially when preparing 99m-Tc labeled sulfur colloid for lymph nodes study.<xref ref-type="bibr" rid="article-125773.r17">[17]</xref>&#x000a0;The former interferes with its preparation and leads to the precipitation of colloid. Besides, it affects the distribution of radiopharmaceutical. There is an increased lung activity with 99m-Tc sulfur colloid in an aluminum-containing eluent and increased liver uptake with 99m-Tc-MDP. Agglutination of 99m-Tc labeled RBCs is another issue encountered with aluminum. The standard limit is less than 10 micrograms/mL, measured using a qualitative spot test utilizing aurin tricarboxylic acid.<xref ref-type="bibr" rid="article-125773.r18">[18]</xref></p>
        <p>
<bold>Radiochemical Impurity</bold>
</p>
        <p>The pertechnetate exhibits a varied range of valency, between -1 to +7, depending upon pH, presence of a reducing, or an oxidizing agent. Sodium pertechnetate (TcO4-) is the desired form with a valency of +7. Other reduced oxidation states such as +4, +5, or +6 are called radiochemical impurities detected by thin-layer chromatography. Although infrequent, the determination of these radiochemical impurities is often considered if labeling has a low yield. More than or equal to 95% of 99m-Tc activity should be in the +7 oxidation state for ideal labeling with a pharmaceutical.<xref ref-type="bibr" rid="article-125773.r19">[19]</xref></p>
      </sec>
      <sec id="article-125773.s4" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>The generator plays a central role in nuclear medicine imaging and therapeutics. Though multiple modifications have been made in the past years, they rely on a simple column chromatography technique. As more and more generator manufacturers are coming up in the market, there is a need to standardize safe permissible impurities limits to eliminate unnecessary radiation exposure to the healthcare workers and the patients. Also, there is a need to look up alternatives of 99m-Tc due to a global shortage of Molybdenum-99.<xref ref-type="bibr" rid="article-125773.r20">[20]</xref></p>
      </sec>
      <sec id="article-125773.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=125773&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=125773">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/125773/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=125773">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-125773.s6">
        <title>References</title>
        <ref id="article-125773.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drozdovitch</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Brill</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Callahan</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Clanton</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>DePietro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goldsmith</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Greenspan</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Hays</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Ponto</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Shreeve</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Melo</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Linet</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Use of radiopharmaceuticals in diagnostic nuclear medicine in the United States: 1960-2010.</article-title>
            <source>Health Phys</source>
            <year>2015</year>
            <month>May</month>
            <volume>108</volume>
            <issue>5</issue>
            <fpage>520</fpage>
            <page-range>520-37</page-range>
            <pub-id pub-id-type="pmid">25811150</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vucina</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Technetium-99m production for use in nuclear medicine].</article-title>
            <source>Med Pregl</source>
            <year>2000</year>
            <season>Nov-Dec</season>
            <volume>53</volume>
            <issue>11-12</issue>
            <fpage>631</fpage>
            <page-range>631-4</page-range>
            <pub-id pub-id-type="pmid">11320753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dash</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Knapp</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Pillai</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>99Mo/(99m)Tc separation: an assessment of technology options.</article-title>
            <source>Nucl Med Biol</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>167</fpage>
            <page-range>167-76</page-range>
            <pub-id pub-id-type="pmid">23142410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castronovo</surname>
                <given-names>FP</given-names>
              </name>
            </person-group>
            <article-title>Technetium-99m: basic nuclear physics and chemical properties.</article-title>
            <source>Am J Hosp Pharm</source>
            <year>1975</year>
            <month>May</month>
            <volume>32</volume>
            <issue>5</issue>
            <fpage>480</fpage>
            <page-range>480-8</page-range>
            <pub-id pub-id-type="pmid">238387</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dash</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chakravarty</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ram</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pillai</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Wagh</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Biswas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Development of a 99Mo/99mTc generator using alumina microspheres for industrial radiotracer applications.</article-title>
            <source>Appl Radiat Isot</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>70</volume>
            <issue>1</issue>
            <fpage>51</fpage>
            <page-range>51-8</page-range>
            <pub-id pub-id-type="pmid">21820904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tippetts</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Kenney</surname>
                <given-names>GN</given-names>
              </name>
            </person-group>
            <article-title>Elution parameters of the 99Mo-99mTc generator.</article-title>
            <source>J Nucl Med</source>
            <year>1969</year>
            <month>Aug</month>
            <volume>10</volume>
            <issue>8</issue>
            <fpage>550</fpage>
            <page-range>550-2</page-range>
            <pub-id pub-id-type="pmid">4893098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chattopadhyay</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>A novel technique for the effective concentration of 99mTc from a large alumina column loaded with low specific-activity (n,gamma)-produced 99Mo.</article-title>
            <source>Appl Radiat Isot</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>66</volume>
            <issue>10</issue>
            <fpage>1295</fpage>
            <page-range>1295-9</page-range>
            <pub-id pub-id-type="pmid">18387810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vigne</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Emery</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lemarie</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chavent</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hallouard</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Le Guludec</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rouzet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fraysse</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Mil</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Fractionated elution of 99Mo/99mTc generators using calibrated vials.</article-title>
            <source>Nucl Med Commun</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>39</volume>
            <issue>9</issue>
            <fpage>865</fpage>
            <page-range>865-869</page-range>
            <pub-id pub-id-type="pmid">29975214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bauer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pabst</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>Tc-generators - yield of 99mTc and ratio to 'inactive' 99Tc.</article-title>
            <source>Eur J Nucl Med</source>
            <year>1982</year>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-6</page-range>
            <pub-id pub-id-type="pmid">7060601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r10">
          <label>10</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Kane</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Padda</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <chapter-title>Technetium-99m</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>4</month>
            <day>24</day>
            <pub-id pub-id-type="pmid">32644439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hidalgo</surname>
                <given-names>JU</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Wooten</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Prediction of technetium-99m yield from molybdenum-99 generators.</article-title>
            <source>J Nucl Med</source>
            <year>1967</year>
            <month>Jun</month>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>426</fpage>
            <page-range>426-9</page-range>
            <pub-id pub-id-type="pmid">6029287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hou</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Use of (99m)Tc from a commercial (99)Mo/(99m)Tc generator as yield tracer for the determination of (99)Tc at low levels.</article-title>
            <source>Appl Radiat Isot</source>
            <year>2007</year>
            <month>May</month>
            <volume>65</volume>
            <issue>5</issue>
            <fpage>610</fpage>
            <page-range>610-8</page-range>
            <pub-id pub-id-type="pmid">17350274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waight</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Cunnane</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Millar</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Effect of 99Tc on the radiochemical purity of 99mTc radiopharmaceuticals.</article-title>
            <source>Nucl Med Commun</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>32</volume>
            <issue>8</issue>
            <fpage>752</fpage>
            <page-range>752-6</page-range>
            <pub-id pub-id-type="pmid">21597394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vucina</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>[Radionuclide purity of 99mTC eluate for use in nuclear medicine].</article-title>
            <source>Med Pregl</source>
            <year>1996</year>
            <volume>49</volume>
            <issue>1-2</issue>
            <fpage>41</fpage>
            <page-range>41-4</page-range>
            <pub-id pub-id-type="pmid">8643069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lo</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Berke</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Potsaid</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>A simple method of correcting 99Mo breakthrough from a 99mTc-99Mo generator.</article-title>
            <source>Radiology</source>
            <year>1969</year>
            <month>Nov</month>
            <volume>93</volume>
            <issue>5</issue>
            <fpage>1198</fpage>
            <page-range>1198-9</page-range>
            <pub-id pub-id-type="pmid">5350697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saegusa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Arimizu</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nakata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tohyama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shiina</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>[Assay of radioactive impurity in 99mTc-pertechnetate eluted from 99Mo-99mTc generator (author's transl)].</article-title>
            <source>Radioisotopes</source>
            <year>1980</year>
            <month>Feb</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>94</fpage>
            <page-range>94-6</page-range>
            <pub-id pub-id-type="pmid">7384574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r17">
          <label>17</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ranzenberger</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <chapter-title>Lymphoscintigraphy</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>2</month>
            <day>16</day>
            <pub-id pub-id-type="pmid">33085360</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hammermaier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Reich</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>B&#x000f6;gl</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Chemical, radiochemical, and radionuclide purity of eluates from different commercial fission 99Mo/99mTc generators.</article-title>
            <source>Eur J Nucl Med</source>
            <year>1986</year>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-6</page-range>
            <pub-id pub-id-type="pmid">3015622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maioli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Luciniani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Strinchini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tagliabue</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Del Sole</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Quality control on radiochemical purity in Technetium-99m radiopharmaceuticals labelling: three years of experience on 2280 procedures.</article-title>
            <source>Acta Biomed</source>
            <year>2017</year>
            <month>Apr</month>
            <day>28</day>
            <volume>88</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-56</page-range>
            <pub-id pub-id-type="pmid">28467334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-125773.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lyra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Charalambatou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Roussou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fytros</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baka</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Alternative production methods to face global molybdenum-99 supply shortage.</article-title>
            <source>Hell J Nucl Med</source>
            <year>2011</year>
            <season>Jan-Apr</season>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-55</page-range>
            <pub-id pub-id-type="pmid">21512666</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
